These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6554023)

  • 1. On the interaction between human plasma kallikrein and C1-esterase inhibitor.
    Nilsson T
    Thromb Haemost; 1983 Jun; 49(3):193-5. PubMed ID: 6554023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the role of the C1-esterase inhibitor in cold urticaria.
    Nilsson T; Bäck O
    Acta Derm Venereol; 1984; 64(3):197-202. PubMed ID: 6204479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.
    Schapira M; Scott CF; Colman RW
    Biochemistry; 1981 May; 20(10):2738-43. PubMed ID: 6910423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of elevated C1-esterase inhibitor levels on elastase release in vitro--a proposed model of shock (ECC).
    Heller W; Fuhrer G; Hoberg S; Hoffmeister HE; Philapitsch A
    Prog Clin Biol Res; 1987; 236A():107-14. PubMed ID: 3649819
    [No Abstract]   [Full Text] [Related]  

  • 5. Transient kinetics of intracomplex electron transfer in the human cytochrome b5 reductase-cytochrome b5 system: NAD+ modulates protein-protein binding and electron transfer.
    Meyer TE; Shirabe K; Yubisui T; Takeshita M; Bes MT; Cusanovich MA; Tollin G
    Arch Biochem Biophys; 1995 Apr; 318(2):457-64. PubMed ID: 7733677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1 inhibitor: the main inhibitor of human plasma kallikrein.
    Trumpi-Kalshoven MM; Kluft C
    Adv Biosci; 1978 Jul; 17():93-101. PubMed ID: 90628
    [No Abstract]   [Full Text] [Related]  

  • 7. Tryptophan 60-D in the B-insertion loop of thrombin modulates the thrombin-antithrombin reaction.
    Rezaie AR
    Biochemistry; 1996 Feb; 35(6):1918-24. PubMed ID: 8639675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-stimulated modification of C1-inhibitor by subcomponent C1s of human complement.
    Weiss V; Engel J
    Hoppe Seylers Z Physiol Chem; 1983 Mar; 364(3):295-301. PubMed ID: 6602754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of formation of the complex between transferrin and bismuth, and interaction with transferrin receptor 1.
    Miquel G; Nekaa T; Kahn PH; Hémadi M; El Hage Chahine JM
    Biochemistry; 2004 Nov; 43(46):14722-31. PubMed ID: 15544343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different kinetic pathways of the binding of two biphenyl analogues of colchicine to tubulin.
    Dumortier C; Gorbunoff MJ; Andreu JM; Engelborghs Y
    Biochemistry; 1996 Apr; 35(14):4387-95. PubMed ID: 8605187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein.
    Heeb MJ; España F
    Blood Cells Mol Dis; 1998 Dec; 24(4):412-9. PubMed ID: 9851894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measurement of plasma kallikrein inhibitor using purified human plasma kallikrein].
    Haneda Y; Denpo Y; Chiba Y; Yoshida Y
    Rinsho Ketsueki; 1983 Mar; 24(3):225-31. PubMed ID: 6193294
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of human plasma kallikrein and its light chain with C1 inhibitor.
    van der Graaf F; Koedam JA; Griffin JH; Bouma BN
    Biochemistry; 1983 Sep; 22(20):4860-6. PubMed ID: 6556071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin binding and augmentation of C1 inhibitor activity.
    Caldwell EE; Andreasen AM; Blietz MA; Serrahn JN; VanderNoot V; Park Y; Yu G; Linhardt RJ; Weiler JM
    Arch Biochem Biophys; 1999 Jan; 361(2):215-22. PubMed ID: 9882449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of C1 inactivator-plasma kallikrein complexes in purified systems and in plasma.
    Lewin MF; Kaplan AP; Harpel PC
    J Biol Chem; 1983 May; 258(10):6415-21. PubMed ID: 6343376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
    Walter M; Plotnick M; Schechter NM
    Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus: kinetic characterization of its interactions with beta-lactams using electrospray mass spectrometry.
    Lu WP; Sun Y; Bauer MD; Paule S; Koenigs PM; Kraft WG
    Biochemistry; 1999 May; 38(20):6537-46. PubMed ID: 10350472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorine dioxide oxidation of guanosine 5'-monophosphate.
    Napolitano MJ; Stewart DJ; Margerum DW
    Chem Res Toxicol; 2006 Nov; 19(11):1451-8. PubMed ID: 17112232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin modulation of human plasma kallikrein on different substrates and inhibitors.
    Gozzo AJ; Nunes VA; Cruz-Silva I; Carmona AK; Nader HB; Faljoni-Alario A; Sampaio MU; Araújo MS
    Biol Chem; 2006 Aug; 387(8):1129-38. PubMed ID: 16895484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.